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Abstract: The present study was aimed to evaluate the impact of The Trivedi Effect® - Energy of Consciousness Healing 
Treatment (Biofield Energy Healing Treatment) on magnesium gluconate for the change in the structural properties and 
isotopic abundance ratio (PM+1/PM and PM+2/PM) using LC-MS and NMR spectroscopy. Magnesium gluconate was divided into 
two parts – one part was control, and another part was treated with The Trivedi Effect
®
- Biofield Energy Healing Treatment 
remotely by twenty renowned Biofield Energy Healers and defined as The Trivedi Effect
® 
treated sample. The LC-MS analysis 
of both the control and treated samples revealed the presence of the mass of the protonated magnesium gluconate at m/z 415 at 
the retention time of 1.52 min with almost similar fragmentation pattern. The relative peak intensities of the fragment ions of 
the treated sample were significantly altered compared with the control sample. The proton and carbon signals for CH, CH2 
and CO groups in the proton and carbon NMR spectra were found almost similar for the control and the treated samples. The 
isotopic abundance ratio analysis revealed that the isotopic abundance ratios of PM+1/PM (
2
H/
1
H or 
13
C/
12
C or 
17
O/
16
O or 
25
Mg/
24
Mg) and PM+2/PM (
18
O/
16
O or 
26
Mg/
24
Mg) were significantly decreased in the treated sample by 35.97% and 66.77%, 
respectively compared with the control sample. Briefly,
 13
C, 
2
H, 
17
O, and 
25
Mg contributions from (C12H23MgO14)
+
 to m/z 416; 
18
O and 
26
Mg contributions from (C12H23MgO14)
+
 to m/z 417 in the treated sample were significantly reduced compared with 
the control sample. Thus, The Trivedi Effect
®
 treated magnesium gluconate could be valuable for designing better 
pharmaceutical and/or nutraceutical formulations through its changed physicochemical and thermal properties, which might be 
providing better therapeutic response against various diseases such as diabetes mellitus, allergy, aging, inflammatory diseases, 
immunological disorders, and other chronic infections. The Trivedi Effect
®
 Treated magnesium gluconate might be supportive 
to design the novel potent enzyme inhibitors using its kinetic isotope effects. 
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1. Introduction 
Magnesium ion (Mg
2+
) is an essential nutrient as a 
structural constituent of bone, regulator of more than 300 
enzymes, cofactor for synthesis of DNA, RNA, reproduction 
and protein, vital coherent controller of glycolysis and the 
Krebs cycle [1-3]. Magnesium gluconate, the organometallic 
salt of magnesium with gluconic acid, is useful for the 
prevention and treatment of many diseases such as 
cardiovascular diseases, diabetes mellitus, allergy, 
inflammatory diseases, immunological disorders, 
Alzheimer’s disease, asthma, pre-eclampsia, eclampsia, 
cancer, oxidative stress induced ischemia/reperfusion injury, 
etc. [4-9]. It can be used as neuroprotective [10], an oral 
tocolytic agent [11], and also in a skin-tightening cosmetic 
composition [12]. Magnesium gluconate displayed the 
highest bioavailability and most physiologically acceptable 
salt among other magnesium salts like chloride, sulfate, 
carbonate, acetate, citrate, lactate, aspartate, etc. [8, 13]. 
Therefore, magnesium gluconate was considered as one of 
the components in a novel proprietary herbomineral 
formulation for the source of magnesium ion. This 
herbomineral formulation which is designed as nutraceutical 
supplement can be used for the prevention and treatment of 
various human diseases. 
Since ancient times, many different cultures, religions and 
systems of belief have recognized a living force that 
preserves and inhabits every living organism. This force is 
the source of ‘life’ and has been called various names, such 
as prana by the Hindus, qi or chi by the Chinese, and ki by 
the Japanese. This is believed to co-relate with the soul, spirit 
and mind. This hypothetical vital force has been scientifically 
evaluated and is now considered the Bioenergetics Field. The 
Biofield Energy is a dynamic electromagnetic field 
surrounding the human body, resulting from the continuous 
emission of low-level light, heat, and acoustical energy from 
the body. Biofield Energy is infinite, para-dimensional and 
can freely flow between the human and environment [14, 
15]. F Sances et al. reported that Biofield Energy can be 
transmitted into any living organism(s) or nonliving object(s) 
around the globe with scientifically measurable effect 
through the intentional mental energies by specific energy 
healers [16]. The object or recipient always receives the 
energy from the ionosphere of the earth, the “universal 
energy field” and responds in a useful way. This process is 
known as The Trivedi Effect
®
 - Biofield Energy Healing 
Treatment [17]. Biofield (Putative Energy Field) based 
Energy Therapies are used worldwide to promote health and 
healing. The National Center of Complementary and 
Integrative Health (NCCIH) has recognized and accepted 
Biofield Energy Healing as a Complementary and Alternative 
Medicine (CAM) health care approach in addition to other 
therapies, medicines and practices such as natural products, 
deep breathing, yoga, Tai Chi, Qi Gong, 
chiropractic/osteopathic manipulation, meditation, massage, 
special diets, homeopathy, progressive relaxation, guided 
imagery, acupressure, acupuncture, relaxation techniques, 
hypnotherapy, healing touch, movement therapy, pilates, 
rolfing structural integration, mindfulness, Ayurvedic 
medicine, traditional Chinese herbs and medicines, 
naturopathy, essential oils, aromatherapy, Reiki, cranial 
sacral therapy and applied prayer (as is common in all 
religions, like Christianity, Hinduism, Buddhism and 
Judaism) [18]. Biofield Energy Treatment (The Trivedi 
Effect
®
) has been drawn attention more in the recent times 
for its scientifically measurable capability to transform the 
characteristic properties of a wide varieties living and non-
living substances such as animals [19], cancer cells [20], 
microbes [21, 22], plants [23, 24], medium [25, 26], 
materials [27, 28], pharmaceuticals [29, 30], nutraceuticals 
[31, 32], organic compounds [33-35]. The scientific study 
indicated that Biofield Energy Healing Treatment (The 
Trivedi Effect
®
) might be an alternate method for increasing 
or decreasing the natural isotopic abundance ratio of the 
substances [36-39]. The stable isotope ratio analysis has the 
wide applications in several scientific fields for 
understanding the isotope effects resulting from the variation 
of the isotopic composition of the molecule [40, 41]. 
Conventional mass spectrometry (MS) techniques such as 
liquid chromatography-mass spectrometry (LC-MS), gas 
chromatography-mass spectrometry (GC-MS) are widely 
used for isotope ratio analysis with sufficient precision [42]. 
Hence, LC-MS and NMR (Nuclear Magnetic Resonance) 
methods were applied in this study to characterize the 
structural properties of the Biofield Energy Treated and 
untreated magnesium gluconate qualitatively for the purpose 
of the pharmaceutical and nutraceutical industrial 
applications. Consequently, LC-MS based isotopic 
abundance ratio (PM+1/PM and PM+2/PM) analysis in both the 
Biofield Energy Treated and untreated samples was designed 
to explore the effect of The Trivedi Effect
®
- Biofield Energy 
Healing on the isotopic abundance ratio in magnesium 
gluconate. 
2. Materials and Methods 
2.1. Chemicals and Reagents 
Magnesium gluconate hydrate was purchased from Tokyo 
Chemical Industry Co., Ltd. (TCI), Japan. All other 
chemicals used in the experiment were of analytical grade 
available in India. 
2.2. Energy of Consciousness Treatment Strategies 
Magnesium gluconate was one of the components of the 
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new proprietary herbomineral formulation, which was 
developed by our research team and was used per se as the 
test compound for the current study. The test compound was 
divided into two parts, one part of the test compound did not 
receive any sort of treatment and was defined as the untreated 
or control magnesium gluconate sample. The second part of 
the test compound, which was denoted as The Trivedi Effect
®
 
Treated sample, was treated with The Trivedi Effect
®
 - 
Energy of Consciousness Healing Treatment (Biofield 
Energy Healing Treatment) by a group of twenty renowned 
Biofield Energy Healers remotely. Thus, Biofield Energy 
Treated sample was also known as The Trivedi Effect
®
 
Treated sample. Eighteen Biofield Energy Healers were 
remotely located in the U.S.A. and two of which was 
remotely located in Canada, while the test compound was 
located in the research laboratory of GVK Biosciences Pvt. 
Ltd., Hyderabad, India. The Trivedi Effect
®
 - Energy of 
Consciousness Healing Treatment (Biofield Energy Healing 
Treatment) was provided for 5 minutes through the Healer’s 
Unique Energy Transmission process remotely to the test 
compound, which was kept under laboratory conditions. 
None of the Biofield Energy Healers in this study visited the 
laboratory in person, nor had any contact with the 
compounds. Similarly, the control compound was subjected 
to “sham” healer for 5 minutes, under the same laboratory 
conditions. The sham healer did not have any knowledge 
about The Trivedi Effect
®
 treatment. After that, The Trivedi 
Effect
® 
treated and untreated samples were kept in similar 
sealed conditions and characterized thoroughly by LC-MS 
and NMR spectroscopy. 
2.3. Characterization 
2.3.1. Liquid Chromatography Mass Spectrometry (LC-MS) 
Analysis 
Liquid chromatography was performed using The Waters
®
 
ACQUITY UPLC, Milford, MA, USA equipped with a 
binary pump (The Waters
®
 BSM HPLC pump), autosampler, 
column heater and a photo-diode array (PDA) detector. The 
column used for the study was a reversed phase Acquity 
BEH shield RP C18 (150 X 3.0 mm, 2.5 µm). The column 
temperature was kept constant at 40°C. The mobile phase 
was 2mM ammonium acetate in water as mobile phase A and 
acetonitrile as mobile phase B. Chromatographic separation 
was achieved with following gradient program: 0 min – 
5%B; 1 min – 5%B; 15 min - 97%B; 20 min – 97%B; 21 min 
– 5%B; 25 min – 5%B. The flow rate was at a constant flow 
rate of 0.4 mL/min. The control and treated samples were 
dissolved in a mixture of water and methanol (60:40 v/v) to 
prepare a 1 mg/mL stock solution. An aliquot of 2 µL of the 
stock solution was used for analysis by LC-ESI-MS and the 
total run time was 25 min. Mass spectrometric analysis was 
accompanied on a Triple Quad (Waters Quattro Premier XE, 
USA) mass spectrometer equipped with an electrospray 
ionization (ESI) source with the following parameters: 
electrospray capillary voltage 3.5 kV; source temperature 
100°C; desolvation temperature 350°C; cone voltage 30 V; 
desolvation gas flow 1000 L/h and cone gas flow 60 L/h. 
Nitrogen was used in the electrospray ionization source. The 
multiplier voltage was set at 650 V. LC-MS was taken in 
positive ionization mode and with the full scan (m/z 50-
1400). The total ion chromatogram, % peak area and mass 
spectrum of the individual peak (appeared in LC) were 
recorded. 
2.3.2. Isotopic Abundance Ratio Analysis 
The relative intensity of the peak in the mass spectra is 
directly proportional to the relative isotopic abundance of the 
molecule and the isotopic abundance ratio analysis was 
followed the scientific literature reported [36-39] method 
described as below: 
PM stands for the relative peak intensity of the parent 
molecular ion [M
+
] expressed in percentage. In other way, it 
indicates the probability to A elements having only one 
natural isotope in appreciable abundance (for e.g. 
12
C, 
1
H, 
16
O, 
24
Mg, etc.) contributions to the mass of the parent 
molecular ion [M
+
]. 
PM+1 represents the relative peak intensity of the isotopic 
molecular ion [(M+1)
+
] expressed in percentage 
= (no. of 
13
C x 1.1%) + (no. of 
15
N x 0.40%) + (no. of 
2
H x 
0.015%) + (no. of 
17
O x 0.04%) + (no. of 
25
Mg x 12.66%) 
i.e. the probability to A + 1 elements having an isotope that 
has one mass unit heavier than the most abundant isotope (for 
e.g. 
13
C, 
2
H, 
17
O, 
25
Mg, etc.) contributions to the mass of the 
isotopic molecular ion [(M+1)
+
]. 
PM+2 represents the relative peak intensity of the isotopic 
molecular ion [(M+2)
+
] expressed in the percentage 
= (no. of 
18
O x 0.20%) + (no. of 
26
Mg x 13.94%) 
i.e. the probability to have A + 2 elements having an 
isotope that has two mass unit heavier than the most 
abundant isotope (for e.g.
 18
O, 
26
Mg, etc.) contributions to the 
mass of isotopic molecular ion [(M+2)
+
]. 
Table 1. The isotopic composition (i.e. the natural isotopic abundance) of the 
elements. 
Element Symbol Mass 
% Natural 
Abundance 
A+1 
Factor 
A+2 
Factor 
Hydrogen 1H 1 99.9885   
 2H 2 0.0115 0.015nH  
Carbon 12C 12 98.892   
 13C 13 1.108 1.1 nC  
Oxygen 16O 16 99.762   
 17O 17 0.038 0.04 nO  
 18O 18 0.200  0.20 nO 
Magnesium 24Mg 24 78.99   
 25Mg 25 10.00 12.66 nMg  
 26Mg 26 11.01  13.94 nMg 
A represents element, n represents the number of the 
element (i.e. C, H. O, Mg, etc.) 
The value of the natural isotopic abundance of the 
elements used here for the theoretical calculation are 
achieved from the scientific literature and presented in the 
Table 1 [43, 44]. 
Isotopic abundance ratio for A + 1 elements = PM+1/PM 
Similarly, isotopic abundance ratio for A + 2 elements = 
PM+2/PM 
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Percentage (%) change in isotopic abundance ratio = 
[(IARTreated – IARControl)/ IARControl) x 100], 
Where, IARTreated = isotopic abundance ratio in the Biofield 
Energy Treated sample and IARControl = isotopic abundance 
ratio in the control sample. 
2.3.3. Nuclear Magnetic Resonance (NMR) Analysis 
1
H NMR spectra were recorded in a 400 MHZ VARIAN 
FT-NMR spectrometer at room temperature. Data refer to 
solutions in D2O with the residual solvent protons as internal 
references. 
1
H NMR multiplicities were designated as singlet 
(s), doublet (d), triplet (t), multiplet (m), and broad (br). 
13
C 
NMR spectra were measured at 100 MHz on a VARIAN FT-
NMR spectrometer at room temperature. Chemical shifts (δ) 
were in parts per million (ppm) relative to the solvent’s 
residual proton chemical shift (D2O, δ = 4.65 ppm) and 
solvent’s residual carbon chemical shift (D2O, δ = 0 ppm). 
3. Results and Discussion 
3.1. Liquid Chromatography-Mass Spectrometry (LC-MS) 
Analysis 
The liquid chromatograms of both the control and treated 
magnesium gluconate. 
(Figure 1) exhibited a sharp peak at the retention time (Rt) 
of 1.52 min. This result clearly indicated that the 
polarity/affinity of The Trivedi Effect
®
 - Biofield Energy 
Treated sample remained unchanged compared with the 
control sample. 
 
Figure 1. Liquid chromatograms of the control and The Trivedi Effect®- Biofield Energy Treated magnesium gluconate. 
The ESI-MS spectra of both the control and treated magnesium gluconate at Rt of 1.52 min as shown in the Figure 2 
revealed the presence of the mass of magnesium gluconate at m/z 415 [M + H]
+
 (calcd for C12H23MgO14
+
, 415). 
 
Figure 2. The ESI-MS spectra of the control and Biofield Energy Treated magnesium gluconate. 
The typical fragment ion peaks in the lower m/z region of 
the protonated magnesium gluconate ion [M]
+
 (m/z 415) were 
observed in both the control and the treated samples at m/z 
402 [M – H2O + 6H]
+
 (calcd for C12H26MgO13
4+
, 402), 379 
[M – 2H2O + H]
+
 (calcd for C12H19MgO12
+
, 379), 361 [M – 
3H2O + H]
+
 (calcd for C12H17MgO11
+
, 361), 342 [M – 4H2O]
+
 
(calcd for C12H14MgO10
2+
, 342). By this way removing water 
along with other groups like alkyl, magnesium gluconate 
produces different fragment ion peaks at m/z 320, 307, 284, 
279, 225, 206, 183, 179, 165, 135, 123, and 100 which were 
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observed in the ESI-MS spectra of the control and treated 
samples (Figure 2). 
 
 
Figure 3. Proposed fragmentation pathway of magnesium gluconate. 
These ions correspond to the following molecular formula 
C10H16MgO10
+
, C9H15MgO10
+
, C9H8MgO9
2+
, C9H3MgO9
•2+
, 
C8H9MgO6
+
, C8H6MgO5
2+
, C6H7MgO5
+
, C6H11O6
+
, C5H9O6
+
, 
C5H11O4
+
, C4H11O4
+
, and C4H4O3
2+ 
respectively as shown in 
the Figure 3. Two fragment ion peaks at m/z 254 and 114 that 
are corresponded to the molecular formula C9H10MgO7
2+
 and 
C5H6O3
2+
, respectively were observed in the control sample. 
Consequently, the treated sample exhibited fragment ions at 
m/z 253 and 115 that are corresponded to the molecular 
formula C9H9MgO7
2+•
 and C5H7O3
+
, respectively. The ESI-
MS spectra of the control and treated samples (Figure 2) 
displayed almost similar type fragmentation pattern. The 
fragment ion peak at m/z 165 corresponding to C5H9O6
+
 
exhibited 100% relative peak intensity in both the control and 
the treated ESI-MS spectra (Figure 2). The relative peak 
intensities of the other ion peaks in The Trivedi Effect
® 
Treated sample were significantly altered compared with the 
control sample. 
3.2. Isotopic Abundance Ratio Analysis 
The molecular formula of magnesium gluconate is 
C12H22MgO14. But, in the ESI-MS spectra, it existed as a 
protonated molecular ion at m/z 415 (C12H23MgO14
+
) 
showing 16.76% (control) and 30.75% (treated) relative 
intensities. The theoretical calculation of PM+1 and PM+2 for 
the protonated magnesium gluconate was presented as 
below: 
P (
13
C) = [(12 x 1.1%) x 16.76% (the actual size of the M
+
 
peak)] / 100% = 2.21% 
P (
2
H) = [(23 x 0.015%) x 16.76%] / 100%= 0.06% 
P (
17
O) = [(14 x 0.04%) x 16.76%] / 100% = 0.09% 
P (
25
Mg) = [(1 x 12.66%) x 16.76%] / 100% = 2.12% 
PM+1 i.e. 
13
C, 
2
H, 
17
O, and 
25
Mg contributions from 
(C12H23MgO14)
+
 to m/z 416 = 4.48% 
From the above calculation, it has been found that 
13
C and 
25
Mg have major contribution to m/z 416. 
In the similar way, PM+2 can be calculated as follow: 
P (
18
O) = [(14 x 0.20%) x 16.76%] / 100% = 0.47% 
P (
26
Mg) = [(1 x 13.94%) x 16.76%] / 100% = 2.34% 
So, PM+2 i.e. 
18
O and 
26
Mg contributions from 
(C12H23MgO14)
+
 to m/z 417 = 2.81%. 
But the experimental data showed the difference due to the 
complexity in the structure. LC-MS spectra of the control and 
treated samples indicated the presence of the mass for the 
protonated magnesium gluconate (m/z 415). Hence, PM, PM+1, 
PM+2 for magnesium gluconate at m/z 415, 416 and 417 of the 
control and treated samples were obtained from the observed 
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relative peak intensities of [M
+
], [(M+1)
+
], and [(M+2)
+
] 
peaks, respectively in the respective ESI-MS spectra are 
presented in Table 2. 
Table 2. Isotopic abundance analysis results of the magnesium gluconate ion in the control and The Trivedi Effect® Treated sample. 
Parameter Control sample The Trivedi Effect® Treated sample 
PM at m/z 415 (%) 16.76 30.75 
PM+1 at m/z 416 (%) 8.29 9.74 
PM+1/PM 0.4946 0.3167 
% Change of isotopic abundance ratio (PM+1/PM) with respect to the control sample  -35.97 
PM+2 at m/z 417 (%) 10.53 6.42 
PM+2/PM 0.6283 0.2088 
% Change of isotopic abundance ratio (PM+2/PM) with respect to the control sample  -66.77 
PM = the relative peak intensity of the parent molecular ion [M
+]; PM + 1 = the relative peak intensity of the isotopic molecular ion [(M+1)
+], PM + 2 = the relative 
peak intensity of the isotopic molecular ion [(M+2)+], and M = mass of the parent molecule. 
The isotopic abundance ratios of PM+1/PM and PM+2/PM in 
the treated sample were significantly decreased by 35.97% 
and 66.77%, respectively compared with the control sample 
(Table 2). So,
 13
C, 
2
H, 
17
O, and 
25
Mg contributions from 
(C12H23MgO14)
+
 to m/z 416; 
18
O and 
26
Mg contributions from 
(C12H23MgO14)
+
 to m/z 417 in The Trivedi Effect
® 
Treated 
sample were significantly reduced compared with the control 
sample. 
Table 3. Possible isotopic bond and their effect in the vibrational energy in 
magnesium gluconate molecule. 
SL 
No. 
Probable 
isotopic bond 
Isotope 
type 
Reduced 
mass (µ) 
Zero point vibrational 
energy (E0) 
1 12C-12C Lighter 6.00 Higher 
2 13C-12C Heavier 6.26 Smaller 
3 1H-12C Lighter 0.92 Higher 
4 2H-12C Heavier 1.04 Smaller 
5 12C-16O Lighter 6.86 Higher 
6 13C-16O Heavier 7.17 Smaller 
7 12C-17O Heavier 7.03 Smaller 
8 12C-18O Heavier 7.20 Smaller 
9 16O-1H Lighter 0.94 Higher 
10 16O-2H Heavier 1.78 Smaller 
11 24Mg-16O Lighter 9.60 Higher 
12 25Mg-16O Heavier 9.76 Smaller 
13 26Mg-16O Heavier 9.91 Smaller 
14 24Mg-17O Heavier 9.95 Smaller 
15 24Mg-18O Heavier 10.29 Smaller 
Scientific literature [37-39, 45] reported that the 
vibrational energy is closely related with the reduced mass 
(µ) of the compound and the alteration of the vibrational 
energy can affect the several properties like physicochemical, 
thermal properties of the molecule. The relation between the 
vibrational energy and the reduced mass (µ) for a diatomic 
molecule (Equation 1) is expressed as below [42, 45]: 
 = 	                                     (1) 
Where E0 = the vibrational energy of a harmonic oscillator 
at absolute zero or zero point energy 
f = force constant 
μ = reduced	mass = 		                      (2) 
Where ma and mb are the masses of the constituent atoms. 
The alteration in the isotopic abundance ratios of 
13
C/
12
C 
for C-O; 
2
H/
1
H for C-H and O-H bonds; 
17
O/
16
O and 
18
O/
16
O 
for C-O bond; 
25
Mg/
24
Mg, 
26
Mg/
24
Mg, 
17
O/
16
O and 
18
O/
16
O 
for Mg-O bond have the significant impact on the ground 
state vibrational energy of the molecule due to the higher 
reduced mass (µ) as shown in the Table 4 that leads to the 
isotope effects of the molecule. 
Mass spectroscopic analysis of the several organic 
compounds revealed that the isotopic abundance of 
[M+1]
+
 and [M+2]
+
 ions were increased or decreased, 
thereby suggesting the change in number of neutrons in 
the molecule. It was then postulated to the alterations in 
atomic mass and atomic charge through possible 
mediation of neutrino oscillation [37-39, 46]. Thus, it is 
assumed that The Trivedi Effect
®
 - Biofield Energy 
Healing Treatment might offer the required energy for the 
neutrino oscillations. The changes of neutrinos inside the 
molecule in turn modified the particle size, chemical 
reactivity, density, thermal behavior, selectivity, binding 
energy, etc. [46]. Kinetic isotope effect that is resultant 
from the variation in the isotopic abundance ratio of one 
of the atoms in the reactants in a chemical reaction is very 
useful to study the reaction mechanism as well as for 
understanding the enzymatic transition state and all 
aspects of enzyme mechanism that is supportive for 
designing enormously effective and specific inhibitors 
[42, 45, 47]. As magnesium is an essential cofactor for 
various enzymatic reactions, The Trivedi Effect
® 
Treated 
magnesium gluconate that had altered isotopic abundance 
ratio might be advantageous for the study of enzyme 
mechanism as well as support in the designing of novel 
potent enzyme inhibitors. 
3.3. Nuclear Magnetic Resonance (NMR) Analysis 
The 
1
H and 
13
C NMR spectra of the control and treated 
magnesium gluconate are presented in the Figures 4 and 5, 
respectively. NMR assignments of the control and Biofield 
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Energy Treated magnesium gluconate are presented in the 
Table 4. 
 
 
Figure 4. The 1H NMR spectra of the control and Biofield Energy Treated magnesium gluconate. 
 
Figure 5. The 13C NMR spectra of the control and Biofield Energy Treated magnesium gluconate. 
Table 4. 1H NMR and 13C NMR spectroscopic data of both the control and Biofield Energy Treated of magnesium gluconate. 
Position 1H NMR δ (ppm) 13C NMR δ (ppm) 
 Number Control Treated Control Treated 
1, 1ꞌ 4H* 3.64 (br s), 3.46 ( dd, J = 12, 4 Hz ) 3.61 (br s), 3.44 ( dd, J =12, 4 Hz ) 62.43 62.41 
2, 2ꞌ 2H* 3.58 (br s) 3.56 (br s) 70.64 70.61 
3, 3ꞌ 2H* 3.61 (br s) 3.58 (br s) 70.94 70.92 
4, 4ꞌ 2H 3.87 (br s) 3.85 (br s) 72.17 72.10 
5, 5ꞌ 2H 4.02 (d, J = 4 Hz) 4.01 ( d, J = 4 Hz ) 73.86 73.83 
6, 6ꞌ --  -- 178.35 178.33 
br- broad, s- singlet, and d-doublet, and dd- doublet of doublet, * These assignments can be switched.
Although magnesium gluconate contains a large number of 
hydroxyl (OH) groups, the proton spectra of both the control 
and treated samples did not show any signal for the hydroxyl 
protons due to the replacement of the hydroxyl protons by 
deuterium from deuterated water, which was used as solvent 
for spectra recording. The signals for the protons coupling of 
CH2 group and adjacent CH protons (2-5) in the gluconic 
acid portion were observed in the control sample in the range 
of δ 3.46 to 4.02 ppm (Table 4), which was almost in 
accordance with the proton spectrum of sodium gluconate 
[48]. Consequently, the proton signals for CH2 and CH 
groups for the treated sample were observed in the range of δ 
3.44 to 4.01 ppm (Table 4). Similarly, the carbon signals for 
CO group, CH2 and CH groups in the 
13
C NMR spectrum of 
the treated sample were slightly decreased compared with the 
control sample (Table 4). So, the structure of the magnesium 
gluconate in the treated samples remained same with the 
control sample. 
4. Conclusions 
The present research work established nicely the structural 
characterization of magnesium gluconate using LC-MS and 
NMR techniques and a significantly impact of The Trivedi 
Effect
® 
- Energy of Consciousness Healing Treatment 
(Biofield Energy Healing Treatment) on the isotopic 
abundance ratios of PM+1/PM and PM+2/PM. The LC-MS 
analysis of the both control and treated samples showed the 
presence of the mass of the protonated magnesium gluconate 
at m/z 415 at the retention time of 1.52 min with the nearly 
same type of fragmentation. The relative peak intensities of the 
fragment ions of the treated sample were significantly altered 
 International Journal of Applied Agricultural Sciences 2017; 3(2): 37-46 44 
 
compared with the control sample. The isotopic abundance 
ratios of PM+1/PM (
2
H/
1
H or 
13
C/
12
C or 
17
O/
16
O or 
25
Mg/
24
Mg) 
and PM+2/PM (
18
O/
16
O or 
26
Mg/
24
Mg) were significantly 
reduced in the treated sample by 35.97% and 66.77%, 
respectively compared with the control sample. Briefly,
 13
C, 
2
H, 
17
O, and 
25
Mg contributions from (C12H23MgO14)
+
 to m/z 
416; 
18
O and 
26
Mg contributions from (C12H23MgO14)
+
 to m/z 
417 in the treated sample were significantly decreased 
compared with the control sample. The treated sample might 
exhibit isotope effects such as altered physicochemical and 
thermal properties, rate of the reaction, selectivity and binding 
energy due to its reduced isotopic abundance ratios of PM+1/PM 
and PM+2/PM compared with the control sample. The treated 
magnesium gluconate might be helpful to understand the 
enzymatic reactions as well as design the novel potent enzyme 
inhibitors by using its kinetic isotope effects. Besides, The 
Trivedi Effect
® 
- Energy of Consciousness Healing Treatment 
(Biofield Energy Healing Treatment) could be a useful 
approach in the design of better nutraceutical and/or 
pharmaceutical formulations that can offer significant 
therapeutic responses against various diseases such as diabetes 
mellitus, allergies and septic shock, stress-related disorders like 
sleep disorder, insomnia, anxiety, depression, Attention Deficit 
Disorder (ADD), Attention Deficit Hyperactive Disorder 
(ADHD), mental restlessness (mind chattering), brain frog, 
low libido, impotency, lack of motivation, mood swings, fear 
of the future, confusion, migraines, headaches, forgetfulness, 
overwhelm, loneliness, worthlessness, indecisiveness, 
frustration, irritability, chronic fatigue, obsessive/compulsive 
behavior and panic attacks, inflammatory diseases and 
immunological disorders like Lupus, Systemic Lupus 
Erythematosus, Hashimoto Thyroiditis, Type 1 Diabetes, 
Asthma, Chronic peptic ulcers, Tuberculosis, Hepatitis, 
Chronic active hepatitis, Celiac Disease (gluten-sensitive 
enteropathy), Addison Disease, Crohn's disease, Graves’ 
Disease, Pernicious and Aplastic Anemia, Sjogren Syndrome, 
Irritable Bowel Syndrome (IBS), Multiple Sclerosis, 
Rheumatoid arthritis, Chronic periodontitis, Ulcerative colitis, 
Chronic sinusitis, Myasthenia Gravis, Atherosclerosis, 
Vasculitis, Dermatitis, Diverticulitis, Rheumatoid Arthritis, 
Reactive Arthritis, Alopecia Areata, Psoriasis, Scleroderma, 
Fibromyalgia, Chronic Fatigue Syndrome and Vitiligo, aging-
related diseases like cardiovascular disease, arthritis, cancer, 
Alzheimer’s disease, dementia, cataracts, osteoporosis, 
diabetes, hypertension, glaucoma, hearing loss, Parkinson’s 
Disease, Huntington’s Disease, Prion Disease, Motor Neurone 
Disease, Spinocerebellar Ataxia, Spinal muscular atrophy, 
Amyotrophic lateral sclerosis, Friedreich’s Ataxia and Lewy 
Body Disease; chronic infections and many more. 
Abbreviations 
A: Element; LC-MS: Liquid chromatography-mass 
spectrometry; M: Mass of the parent molecule; m/z: Mass-to-
charge ratio; n: Number of the element; NMR: Nuclear 
magnetic resonance spectroscopy; PM: The relative peak 
intensity of the parent molecular ion [M
+
]; PM+1: The relative 
peak intensity of isotopic molecular ion [(M+1)
+
]); PM+2: The 
relative peak intensity of isotopic molecular ion [(M+2)
+
]); 
Rt: Retention time. 
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